QXQ yields 18.79% · JNJ yields 2.13%● Live data
📍 QXQ pulled ahead of the other in Year 1
Combined, QXQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QXQ + JNJ for your $10,000?
QXQ is an actively managed fund that aims for capital appreciation and current income through an actively managed portfolio of Nasdaq-100 stocks and an options writing strategy. The fund invests in equity securities, options, or ETFs that seek to replicate the Nasdaq-100 Index. The equity investments may include common and preferred stocks, warrants, convertible securities, futures, forwards, and options. The fund targets an enhanced yield compared to traditional option-based strategies by selling short-term options, which typically generate more income than longer-term options over the same period. Using exposure to the value of the S&P 500 Index or other broad benchmark indices, the put-and-call options strategy selects deep out-of-the-money strike prices expiring within 1-7 days. As such, this may limit participation in potential gains if shares increase in value. The fund may hold short-term US Treasurys as collateral and engage in securities lending.
Full QXQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.